title: Anti-lymphocyte antibody-based immunotherapy in type 1 diabetes.
authors.affiliation: Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. cqx65@yahoo.com
authors.forename: Chang-qing
authors.initials: CQ
authors.lastname: Xia
authors.forename: Yuan-tao
authors.initials: YT
authors.lastname: Liu
authors.forename: Qing-bo
authors.initials: QB
authors.lastname: Guan
authors.forename: Michael
authors.initials: M
authors.lastname: Clare-Salzler
mesh_terms: D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D017252:CD3 Complex / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*
chemical_list: D000906:Antibodies; D018951:Antigens, CD20; D000961:Antilymphocyte Serum; D017252:CD3 Complex